Abnormal histological findings in specimens from female genital organs Save
ICD-10 code: R87.7
Chapter: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Abnormal Histological Findings in Specimens from Female Genital Organs
Abnormal histological findings in specimens from female genital organs can be indicative of various medical conditions. These findings are typically identified through a biopsy, which involves removing a small sample of tissue from the affected area for examination under a microscope.
Some common abnormal histological findings in specimens from female genital organs include:
- Dysplasia: This refers to abnormal growth or development of cells in the tissues lining the cervix, vagina, or vulva. Dysplasia is often caused by the human papillomavirus (HPV) and can lead to the development of cervical cancer if left untreated.
- Endometriosis: This occurs when the tissue that normally lines the inside of the uterus grows outside of it, often on the ovaries, fallopian tubes, or other pelvic organs. Endometriosis can cause pain and infertility.
- Fibroids: These are noncancerous growths that develop in the muscular wall of the uterus. Fibroids can cause heavy menstrual bleeding, pelvic pain, and other symptoms.
- Cancer: Abnormal histological findings can also reveal the presence of cancer in the female genital organs, including cervical, ovarian, and uterine cancer.
If abnormal histological findings are identified in a biopsy, further testing may be required to determine the underlying cause and appropriate treatment. Treatment options may include medications, surgery, or a combination of both.
It's important for women to undergo regular gynecological exams and screening tests, such as Pap smears, to help detect abnormal histological findings early and improve the chances of successful treatment.
In conclusion, abnormal histological findings in specimens from female genital organs can be indicative of various medical conditions, including dysplasia, endometriosis, fibroids, and cancer. Early detection and treatment are key to improving outcomes for these conditions, and regular gynecological exams and screening tests are important tools in achieving this.